title: Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol.
abstract: For cardiovascular biomaterials, thrombosis, thromboembolism and vascular graft occlusion are believed to be precipitated by the adsorption of proteins containing adhesive ligands for platelets. Polyethylene-glycol-diisocyanate (PEG-diisocyanate, 3400 MW) may potentially react with protein amines to form molecular barriers on adsorbed proteins on biomaterials, thereby masking adhesive ligands and preventing acute surface thrombosis. To test this notion, PE, PTFE, and glass microconduits were pre-adsorbed with fibrinogen and treated with PEG-diisocyanate, non-reactive PEG-dihydroxyl, or remained untreated. Following perfusion of 111In-labeled platelets in whole human blood for 1 min (wall shear rate = 312 s(-1)), PEG-diisocyanate treated surfaces experienced 96% (PE), 97% (PTFE) and 94% (glass) less platelet deposition than untreated surfaces. Similar reductions were seen for PEG-diisocyanate versus PEG-dihydroxyl treatment. Low shear perfusions of plasma for 1 h prior to blood contact did not reduce the inhibitory effect of PEG-diisocyanate. Platelet adhesion onto collagen-coated glass coverslips and platelet deposition onto preclotted Dacron were also reduced by treatment with PEG-diisocyanate (93 and 91%, respectively). Protein-reactive PEG may thus have utility in forming molecular barriers on surface-associated proteins to inhibit acute thrombosis on cardiovascular biomaterials.
authors.affiliation: Department of Surgery, University of Pittsburgh Medical Center, PA 15213, USA.
authors.forename: C R
authors.initials: CR
authors.lastname: Deible
authors.forename: P
authors.initials: P
authors.lastname: Petrosko
authors.forename: P C
authors.initials: PC
authors.lastname: Johnson
authors.forename: E J
authors.initials: EJ
authors.lastname: Beckman
authors.forename: A J
authors.initials: AJ
authors.lastname: Russell
authors.forename: W R
authors.initials: WR
authors.lastname: Wagner
mesh_terms: D000327:Adsorption; D001672:Biocompatible Materials / Q000009:adverse effects*; D003094:Collagen / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006331:Heart Diseases / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D017953:Isocyanates; D010973:Platelet Adhesiveness / Q000187:drug effects; D011092:Polyethylene Glycols; D011093:Polyethylene Terephthalates; D011506:Proteins / Q000378:metabolism*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
chemical_list: D001672:Biocompatible Materials; D017953:Isocyanates; D011093:Polyethylene Terephthalates; D011506:Proteins; C114824:polyethylene glycol-diisocyanate; D011092:Polyethylene Glycols; D005340:Fibrinogen; D003094:Collagen